Lincoln is the capital of Nebraska. The city’s drug and alcohol detox network is supported by the concentration of behavioral health providers and a growing infrastructure of public health partnerships.
Nebraska Department of Health and Human Services (DHHS) Licensure Unit licenses all facilities in Lincoln under Title 175 NAC 18 of the Nebraska Administrative Code. This governs SUD treatment center standards that can include staffing, clinical protocols, patient rights and ongoing quality review.
The Nebraska Division of Behavioral Health (DBH) funds and monitors services statewide through six regional behavioral health authorities. The Region V System covers Lincoln and the surrounding southeast Nebraska counties.
The Lincoln-Lancaster County Health Department (LLCHD) is the primary public health authority and leads the Overdose Prevention Coalition. This is an informal network of roughly 20 agencies, care providers and community stakeholders.
The coalition focuses on systematic overdose education, naloxone access and data monitoring. This also includes wastewater surveillance that tracks community drug use trends nearly in real time.
Two recent developments are changing the treatment picture in Lincoln. The Nebraska Legislature passed LB 1325 in 2024. This allowed pharmacies to sell fentanyl test strips over the counter and authorized local public health departments to distribute them for free.
The state’s first round of Opioid Treatment Infrastructure Cash Fund grants was awarded in late 2025. There were $2 million in grants given to CenterPointe to expand short-term residential capacity in Lincoln and $350,000 was granted to Bryan Medical Center.
These grants address the longstanding shortage of residential detox beds. Lincoln has inpatient residential programs, outpatient detox and MAT clinics.
Methamphetamine continues to be the drug most commonly responsible for treatment admissions in Nebraska. Overdose deaths attributed to fentanyl are shaping local harm reduction programs.
